AMRN
Price
$16.73
Change
+$0.08 (+0.48%)
Updated
Jul 3 closing price
Capitalization
357.53M
23 days until earnings call
PFE
Price
$25.38
Change
+$0.06 (+0.24%)
Updated
Jul 3 closing price
Capitalization
157.14B
29 days until earnings call
Interact to see
Advertisement

AMRN vs PFE

Header iconAMRN vs PFE Comparison
Open Charts AMRN vs PFEBanner chart's image
Amarin
Price$16.73
Change+$0.08 (+0.48%)
Volume$83.67K
Capitalization357.53M
Pfizer
Price$25.38
Change+$0.06 (+0.24%)
Volume$27.1M
Capitalization157.14B
AMRN vs PFE Comparison Chart in %
Loading...
AMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PFE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMRN vs. PFE commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMRN is a Buy and PFE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (AMRN: $16.73 vs. PFE: $25.38)
Brand notoriety: AMRN and PFE are both notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: AMRN: 67% vs. PFE: 64%
Market capitalization -- AMRN: $357.53M vs. PFE: $157.14B
AMRN [@Pharmaceuticals: Major] is valued at $357.53M. PFE’s [@Pharmaceuticals: Major] market capitalization is $157.14B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMRN’s FA Score shows that 0 FA rating(s) are green whilePFE’s FA Score has 1 green FA rating(s).

  • AMRN’s FA Score: 0 green, 5 red.
  • PFE’s FA Score: 1 green, 4 red.
According to our system of comparison, PFE is a better buy in the long-term than AMRN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMRN’s TA Score shows that 5 TA indicator(s) are bullish while PFE’s TA Score has 4 bullish TA indicator(s).

  • AMRN’s TA Score: 5 bullish, 4 bearish.
  • PFE’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, AMRN is a better buy in the short-term than PFE.

Price Growth

AMRN (@Pharmaceuticals: Major) experienced а +5.22% price change this week, while PFE (@Pharmaceuticals: Major) price change was +4.70% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +1.19%. For the same industry, the average monthly price growth was +2.56%, and the average quarterly price growth was +9.33%.

Reported Earning Dates

AMRN is expected to report earnings on Jul 30, 2025.

PFE is expected to report earnings on Aug 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+1.19% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PFE($157B) has a higher market cap than AMRN($358M). PFE has higher P/E ratio than AMRN: PFE (74.92) vs AMRN (67.11). AMRN YTD gains are higher at: 72.474 vs. PFE (-0.898). PFE has higher annual earnings (EBITDA): 9.56B vs. AMRN (-50.7M). PFE has more cash in the bank: 12.7B vs. AMRN (321M). AMRN has less debt than PFE: AMRN (8.74M) vs PFE (70.8B). PFE has higher revenues than AMRN: PFE (58.5B) vs AMRN (307M).
AMRNPFEAMRN / PFE
Capitalization358M157B0%
EBITDA-50.7M9.56B-1%
Gain YTD72.474-0.898-8,071%
P/E Ratio67.1174.9290%
Revenue307M58.5B1%
Total Cash321M12.7B3%
Total Debt8.74M70.8B0%
FUNDAMENTALS RATINGS
AMRN vs PFE: Fundamental Ratings
AMRN
PFE
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
4
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9374
PRICE GROWTH RATING
1..100
3651
P/E GROWTH RATING
1..100
10096
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PFE's Valuation (4) in the Pharmaceuticals Major industry is significantly better than the same rating for AMRN (87) in the Pharmaceuticals Other industry. This means that PFE’s stock grew significantly faster than AMRN’s over the last 12 months.

PFE's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as AMRN (100) in the Pharmaceuticals Other industry. This means that PFE’s stock grew similarly to AMRN’s over the last 12 months.

PFE's SMR Rating (74) in the Pharmaceuticals Major industry is in the same range as AMRN (93) in the Pharmaceuticals Other industry. This means that PFE’s stock grew similarly to AMRN’s over the last 12 months.

AMRN's Price Growth Rating (36) in the Pharmaceuticals Other industry is in the same range as PFE (51) in the Pharmaceuticals Major industry. This means that AMRN’s stock grew similarly to PFE’s over the last 12 months.

PFE's P/E Growth Rating (96) in the Pharmaceuticals Major industry is in the same range as AMRN (100) in the Pharmaceuticals Other industry. This means that PFE’s stock grew similarly to AMRN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMRNPFE
RSI
ODDS (%)
Bearish Trend 5 days ago
86%
Bearish Trend 5 days ago
55%
Stochastic
ODDS (%)
Bearish Trend 5 days ago
82%
Bearish Trend 5 days ago
51%
Momentum
ODDS (%)
Bullish Trend 5 days ago
78%
Bullish Trend 5 days ago
55%
MACD
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 5 days ago
48%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
76%
Bullish Trend 5 days ago
57%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
73%
Bullish Trend 5 days ago
51%
Advances
ODDS (%)
Bullish Trend 26 days ago
71%
Bullish Trend 5 days ago
56%
Declines
ODDS (%)
Bearish Trend 11 days ago
88%
Bearish Trend 11 days ago
60%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 5 days ago
57%
Aroon
ODDS (%)
Bullish Trend 5 days ago
74%
Bullish Trend 5 days ago
53%
View a ticker or compare two or three
Interact to see
Advertisement
AMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PFE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
PROS.X0.0383940.002270
+6.28%
Prosper cryptocurrency
NFP.X0.0547000.001265
+2.37%
NFPrompt cryptocurrency
DCR.X15.7674830.168252
+1.08%
Decred cryptocurrency
XVG.X0.0051540.000045
+0.87%
Verge cryptocurrency
BCH.X491.9597802.551575
+0.52%
Bitcoin Cash cryptocurrency

AMRN and

Correlation & Price change

A.I.dvisor tells us that AMRN and OGN have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AMRN and OGN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMRN
1D Price
Change %
AMRN100%
+0.48%
OGN - AMRN
28%
Poorly correlated
-1.87%
PFE - AMRN
27%
Poorly correlated
+0.24%
BIIB - AMRN
21%
Poorly correlated
-0.24%
SCLX - AMRN
20%
Poorly correlated
+1.92%
GRFS - AMRN
20%
Poorly correlated
-0.66%
More

PFE and

Correlation & Price change

A.I.dvisor indicates that over the last year, PFE has been loosely correlated with GSK. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if PFE jumps, then GSK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PFE
1D Price
Change %
PFE100%
+0.24%
GSK - PFE
60%
Loosely correlated
-0.86%
AMGN - PFE
57%
Loosely correlated
+0.47%
ABBV - PFE
55%
Loosely correlated
-0.77%
NVS - PFE
54%
Loosely correlated
-1.54%
BMY - PFE
51%
Loosely correlated
-0.19%
More